The National Institutes of Health National Heart, Lung and Blood Institute awarded a firm fixed price purchase order valued at twelve thousand four hundred dollars and thirty-five cents ($12,400.35) to Qiagen, LLC for maintenance service of a QIASYMPHONY SP 34311 instrument. The contract requires Qiagen to maintain equipment used by the Laboratory of Applied Precision Omics to isolate cell-free DNA from plasma samples of lung transplant patients. Performance will occur in Germantown, Maryland...
This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services, National Institutes of Health Clinical Center, to Qiagen, LLC for QIAGEN QIACUITY MAINTENANCE services. The contract has a potential value of $91,237.95 and a period of performance from April 15, 2024 to April 14, 2025. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics....
This is a $80,260 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V. The contract is not set aside and has a period of performance from March 28, 2019 to April 14, 2021. Qiagen, a global provider of sample and assay technologies, has delivered a range of products and services to federal agencies, including DNA/RNA extraction kits, next-generation sequencing equipment, bioinformatics software, and other...
This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract, valued at $11,047.00, is for a one-year preventative maintenance agreement covering the EZ1 and EZ2 Connect sample prep instruments from August 16, 2024 to August 15, 2025.
Qiagen is an experienced federal contractor, providing a range of sample preparation and molecular diagnostics products...
This is a $97,350.04 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The contract is for QIAGEN EQUIPMENT MAINTENANCE SERVICES and has a period of performance through September 28, 2024. No set-aside designation was used.
Qiagen is a major provider of sample and assay technologies to federal agencies, supporting programs related to biomedical research, public health, law enforcement, and healthcare....
This is a $24,978.80 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, part of the Department of Health and Human Services, to Qiagen, LLC, a foreign-owned for-profit manufacturer of molecular diagnostic products. The contract requires Qiagen to provide QIAsymphony DSP circulating DNA kits to isolate cell-free DNA from plasma samples from lung transplant patients. This is likely in support of the agency's biomedical research and public health programs....
This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international provider Qiagen N.V. The contract has a total ceiling value of $19,008.00 and a period of performance ending on March 30, 2026. The contract does not have a set-aside designation.
Qiagen, LLC will provide a range of products and services to support the NIH's biomedical research, public health, and healthcare programs, including...
This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $15,090 contract is for the supply of unspecified products or services, with a period of performance ending on August 27, 2018. Qiagen has previously provided a range of goods and services to federal agencies, including DNA/RNA extraction kits, sequencing equipment, bioinformatics software, and other...
This is a $17,029.90 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The award does not have a set-aside designation.
Qiagen provides a range of sample and assay technologies supporting federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is associated with a larger Qiagen indefinite delivery vehicle that...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $22,324.00 contract is for the provision of various products and services to support the NIH's biomedical research, public health, and healthcare programs, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems,...